Artificial intelligence electrocardiogram as a novel screening tool to detect and longitudinally monitor high-risk echocardiographic features in hypertrophic cardiomyopathy.

Among these patients, ten developed new high-risk echocardiographic features during a median follow-up of 37 months (interquartile range, 30–53 months), as indicated by an increasing trend in the predicted probability score (19.7% vs. 30.2%, P<0.05).

also in 63,971 other papers